GLOBAL EPILEPSY MONITORING DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Epilepsy Monitoring Devices Market, By Product Type (Conventional and Wearable Devices, Deep Brain Stimulation Devices, Ambulatory EEG Device, Others), By End User (Hospitals, Diagnostic Centers, Specialty Clinics, Others), and Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

On February 29, 2024, Empatica Inc., a healthcare company, launched EpiMonitor, an epilepsy monitoring system for adults and children aged 6 and above. EpiMonitor is an advanced wearable technology that is designed to detect generalized tonic-clonic seizures with high accuracy.
In October 2022, Neuraxpharm, a global healthcare company, announced that it had signed a commercialisation agreement for mjn-SERAS, a wearable medical device that aims to predict the risk of having an epileptic seizure, with mjn-neuro., a manufacturer of medical devices with the aim of improving people's quality of life. With this agreement, Neuraxpharm increases its end-to-end offering for patients with epilepsy and enters the beyond-the-pill solutions market.
In September 2021, The National Institutes of Health awarded a US$ 12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy

Global Epilepsy Monitoring Devices Market Report Snapshots